US Stock MarketDetailed Quotes

ACADIA Pharmaceuticals (ACAD)

Watchlist
  • 25.990
  • -0.540-2.04%
Close Jan 16 16:00 ET
  • 25.990
  • 0.0000.00%
Post 16:10 ET
4.40BMarket Cap16.77P/E (TTM)

ACADIA Pharmaceuticals (ACAD) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
11.27%278.63M
9.34%264.57M
18.70%244.32M
31.85%957.8M
12.36%259.6M
18.28%250.4M
46.44%241.96M
73.75%205.83M
40.45%726.44M
69.27%231.04M
Operating revenue
11.27%278.63M
9.34%264.57M
18.70%244.32M
31.85%957.8M
12.36%259.6M
18.28%250.4M
46.44%241.96M
73.75%205.83M
40.45%726.44M
69.27%231.04M
Cost of revenue
14.80%21.65M
13.74%20.73M
-11.15%20.39M
96.55%81.84M
21.87%21.8M
28.96%18.86M
144.40%18.23M
1,276.78%22.95M
309.58%41.64M
641.44%17.89M
Gross profit
10.99%256.99M
8.98%243.83M
22.44%223.93M
27.91%875.96M
11.56%237.8M
17.49%231.54M
41.80%223.73M
56.58%182.88M
35.05%684.8M
58.98%213.15M
Operating expense
10.67%221.23M
9.40%211.46M
22.05%204.64M
4.42%791.68M
29.52%230.81M
-21.56%199.9M
24.92%193.3M
-1.59%167.67M
3.77%758.18M
-1.07%178.21M
Selling and administrative expenses
0.08%133.4M
14.05%133.51M
17.02%126.37M
20.14%488.43M
16.70%130.08M
36.17%133.29M
21.98%117.06M
6.67%107.99M
10.15%406.56M
6.77%111.47M
Research and development costs
31.86%87.83M
2.25%77.95M
31.14%78.27M
-13.76%303.25M
50.93%100.73M
-57.57%66.61M
29.71%76.23M
-13.69%59.68M
-2.75%351.62M
-11.88%66.74M
Operating profit
12.99%35.76M
6.36%32.37M
26.82%19.29M
214.85%84.28M
-80.00%6.99M
154.77%31.64M
902.21%30.44M
128.39%15.21M
67.18%-73.38M
175.86%34.94M
Net non-operating interest income expense
25.20%8.25M
13.90%7.24M
43.50%7.9M
47.72%25.46M
47.24%7.01M
59.66%6.59M
39.76%6.36M
44.89%5.51M
160.73%17.23M
31.10%4.76M
Non-operating interest income
25.20%8.25M
13.90%7.24M
43.50%7.9M
47.72%25.46M
47.24%7.01M
59.66%6.59M
39.76%6.36M
44.89%5.51M
160.73%17.23M
31.10%4.76M
Other net income (expense)
2.95%593K
53.89%594K
105.59%588K
2,803.46%148.34M
147.09M
-61.80%576K
131.03%386K
-94.10%286K
44.24%5.11M
0
Special income (charges)
----
----
----
--146.52M
----
----
----
----
--0
----
-Gain on sale of property,plant,equipment
----
----
----
--146.52M
----
----
----
----
--0
----
Other non- operating income (expenses)
2.95%593K
53.89%594K
105.59%588K
-64.32%1.82M
--575K
-61.80%576K
131.03%386K
-94.10%286K
44.24%5.11M
--0
Income before tax
14.92%44.6M
8.15%40.21M
32.27%27.78M
605.67%258.08M
305.73%161.09M
174.42%38.81M
486.19%37.18M
146.73%21M
76.09%-51.04M
197.10%39.7M
Income tax
-549.99%-27.18M
257.11%13.55M
97.71%8.79M
208.53%31.62M
384.59%17.34M
-53.65%6.04M
-27.46%3.79M
331.86%4.45M
304.98%10.25M
-829.82%-6.09M
Net income
119.07%71.78M
-20.14%26.67M
14.69%18.99M
469.50%226.45M
213.87%143.74M
150.27%32.77M
2,897.22%33.39M
138.48%16.56M
71.62%-61.29M
209.76%45.8M
Net income continuous Operations
119.07%71.78M
-20.14%26.67M
14.69%18.99M
469.50%226.45M
213.87%143.74M
150.27%32.77M
2,897.22%33.39M
138.48%16.56M
71.62%-61.29M
209.76%45.8M
Minority interest income
Net income attributable to the parent company
119.07%71.78M
-20.14%26.67M
14.69%18.99M
469.50%226.45M
213.87%143.74M
150.27%32.77M
2,897.22%33.39M
138.48%16.56M
71.62%-61.29M
209.76%45.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
119.07%71.78M
-20.14%26.67M
14.69%18.99M
469.50%226.45M
213.87%143.74M
150.27%32.77M
2,897.22%33.39M
138.48%16.56M
71.62%-61.29M
209.76%45.8M
Basic earnings per share
115.00%0.43
-20.00%0.16
10.00%0.11
470.27%1.37
207.14%0.86
150.00%0.2
1,900.00%0.2
137.04%0.1
72.39%-0.37
207.69%0.28
Diluted earnings per share
110.00%0.42
-20.00%0.16
10.00%0.11
467.57%1.36
207.14%0.86
150.00%0.2
1,900.00%0.2
137.04%0.1
72.39%-0.37
207.69%0.28
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 11.27%278.63M9.34%264.57M18.70%244.32M31.85%957.8M12.36%259.6M18.28%250.4M46.44%241.96M73.75%205.83M40.45%726.44M69.27%231.04M
Operating revenue 11.27%278.63M9.34%264.57M18.70%244.32M31.85%957.8M12.36%259.6M18.28%250.4M46.44%241.96M73.75%205.83M40.45%726.44M69.27%231.04M
Cost of revenue 14.80%21.65M13.74%20.73M-11.15%20.39M96.55%81.84M21.87%21.8M28.96%18.86M144.40%18.23M1,276.78%22.95M309.58%41.64M641.44%17.89M
Gross profit 10.99%256.99M8.98%243.83M22.44%223.93M27.91%875.96M11.56%237.8M17.49%231.54M41.80%223.73M56.58%182.88M35.05%684.8M58.98%213.15M
Operating expense 10.67%221.23M9.40%211.46M22.05%204.64M4.42%791.68M29.52%230.81M-21.56%199.9M24.92%193.3M-1.59%167.67M3.77%758.18M-1.07%178.21M
Selling and administrative expenses 0.08%133.4M14.05%133.51M17.02%126.37M20.14%488.43M16.70%130.08M36.17%133.29M21.98%117.06M6.67%107.99M10.15%406.56M6.77%111.47M
Research and development costs 31.86%87.83M2.25%77.95M31.14%78.27M-13.76%303.25M50.93%100.73M-57.57%66.61M29.71%76.23M-13.69%59.68M-2.75%351.62M-11.88%66.74M
Operating profit 12.99%35.76M6.36%32.37M26.82%19.29M214.85%84.28M-80.00%6.99M154.77%31.64M902.21%30.44M128.39%15.21M67.18%-73.38M175.86%34.94M
Net non-operating interest income expense 25.20%8.25M13.90%7.24M43.50%7.9M47.72%25.46M47.24%7.01M59.66%6.59M39.76%6.36M44.89%5.51M160.73%17.23M31.10%4.76M
Non-operating interest income 25.20%8.25M13.90%7.24M43.50%7.9M47.72%25.46M47.24%7.01M59.66%6.59M39.76%6.36M44.89%5.51M160.73%17.23M31.10%4.76M
Other net income (expense) 2.95%593K53.89%594K105.59%588K2,803.46%148.34M147.09M-61.80%576K131.03%386K-94.10%286K44.24%5.11M0
Special income (charges) --------------146.52M------------------0----
-Gain on sale of property,plant,equipment --------------146.52M------------------0----
Other non- operating income (expenses) 2.95%593K53.89%594K105.59%588K-64.32%1.82M--575K-61.80%576K131.03%386K-94.10%286K44.24%5.11M--0
Income before tax 14.92%44.6M8.15%40.21M32.27%27.78M605.67%258.08M305.73%161.09M174.42%38.81M486.19%37.18M146.73%21M76.09%-51.04M197.10%39.7M
Income tax -549.99%-27.18M257.11%13.55M97.71%8.79M208.53%31.62M384.59%17.34M-53.65%6.04M-27.46%3.79M331.86%4.45M304.98%10.25M-829.82%-6.09M
Net income 119.07%71.78M-20.14%26.67M14.69%18.99M469.50%226.45M213.87%143.74M150.27%32.77M2,897.22%33.39M138.48%16.56M71.62%-61.29M209.76%45.8M
Net income continuous Operations 119.07%71.78M-20.14%26.67M14.69%18.99M469.50%226.45M213.87%143.74M150.27%32.77M2,897.22%33.39M138.48%16.56M71.62%-61.29M209.76%45.8M
Minority interest income
Net income attributable to the parent company 119.07%71.78M-20.14%26.67M14.69%18.99M469.50%226.45M213.87%143.74M150.27%32.77M2,897.22%33.39M138.48%16.56M71.62%-61.29M209.76%45.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 119.07%71.78M-20.14%26.67M14.69%18.99M469.50%226.45M213.87%143.74M150.27%32.77M2,897.22%33.39M138.48%16.56M71.62%-61.29M209.76%45.8M
Basic earnings per share 115.00%0.43-20.00%0.1610.00%0.11470.27%1.37207.14%0.86150.00%0.21,900.00%0.2137.04%0.172.39%-0.37207.69%0.28
Diluted earnings per share 110.00%0.42-20.00%0.1610.00%0.11467.57%1.36207.14%0.86150.00%0.21,900.00%0.2137.04%0.172.39%-0.37207.69%0.28
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More